fashion -WSS

fashion

author：Wikipedia 2025-09-06 04:51:37 - browse：984

In the center, three researchers examine a DNA helix. Two people stand in the front, one puts an apple into a capsule containing vegetables, the other holds a check list while standing next to a pile of medicines. On the right side, a scientist injects into mitochondria while another takes notes. A person behind the duo looks at a projection of a brain. On the left side, a client looks at a heart projection from a device held by a robot — biotech coverage from STAT — Adobe

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis.

But if you want to invent lots of potential drugs that could eventually reach the market, you’d be far better off with Johnson & Johnson, Merck, or AstraZeneca.

The analysis, the 13th edition of the Pharmaceutical Innovation and Invention Index, was produced by the consultancy Idea Pharma and released Thursday at the STAT Breakthrough Summit in San Francisco.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： How the first Native Hawaiian psychiatrist helped diversify medicine

hotspot

WSS

Study: Spinal cord stimulation helps patients with paralysis walk again

Dramatically reducing cancer deaths requires the PASTEUR Act

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

ER docs worry over extreme heat as a 'mass casualty event'

What the cancer research community can learn from the Covid response

Meadows told special counsel he could not recall Trump ever declassifying Mar

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Virginia high school admissions case could be legal follow

What the cancer research community can learn from the Covid response

Apple is now the first public company to be valued at $3 trillion

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Psychedelics group wrestles with new pharma identity

FDA advisory panel to debate high blood pressure devices

Hepatitis C has a cure — but many Americans still lack access to it

Can U.S. cancer drug shortages be fixed?

Dobbs anniversary: the lost opportunity of abortion as health care

FDA advisory panel to debate high blood pressure devices

focus

Listen: Vivek Ramaswamy's star turn & leaky drug data

California store owner shot dead in dispute over displaying Pride flag: Police

'Ancient DNA,' 23andMe reveal African American ancestries

Study: Spinal cord stimulation helps patients with paralysis walk again

Abortion policy in the spotlight at Republican debate

Listen: Vivek Ramaswamy's star turn & leaky drug data

hotspot

focus

knowledge

hotspot